Pulmonary Drug Delivery Devices/Systems Market
1 Study Coverage
1.1 Pulmonary Drug Delivery Devices/Systems Product Introduction
1.2 Market by Type
1.2.1 Global Pulmonary Drug Delivery Devices/Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Metered Dose Inhalers
1.2.3 Dry Powder Inhalers
1.2.4 Nebulizers
1.2.5 Accessories
1.3 Market by Application
1.3.1 Global Pulmonary Drug Delivery Devices/Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Homecare
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pulmonary Drug Delivery Devices/Systems Sales Estimates and Forecasts 2017-2028
2.2 Global Pulmonary Drug Delivery Devices/Systems Revenue Estimates and Forecasts 2017-2028
2.3 Global Pulmonary Drug Delivery Devices/Systems Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pulmonary Drug Delivery Devices/Systems Sales by Region
2.4.1 Global Pulmonary Drug Delivery Devices/Systems Sales by Region (2017-2022)
2.4.2 Global Sales Pulmonary Drug Delivery Devices/Systems by Region (2023-2028)
2.5 Global Pulmonary Drug Delivery Devices/Systems Revenue by Region
2.5.1 Global Pulmonary Drug Delivery Devices/Systems Revenue by Region (2017-2022)
2.5.2 Global Pulmonary Drug Delivery Devices/Systems Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pulmonary Drug Delivery Devices/Systems Sales by Manufacturers
3.1.1 Global Top Pulmonary Drug Delivery Devices/Systems Manufacturers by Sales (2017-2022)
3.1.2 Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pulmonary Drug Delivery Devices/Systems in 2021
3.2 Global Pulmonary Drug Delivery Devices/Systems Revenue by Manufacturers
3.2.1 Global Pulmonary Drug Delivery Devices/Systems Revenue by Manufacturers (2017-2022)
3.2.2 Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pulmonary Drug Delivery Devices/Systems Revenue in 2021
3.3 Global Pulmonary Drug Delivery Devices/Systems Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pulmonary Drug Delivery Devices/Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pulmonary Drug Delivery Devices/Systems Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pulmonary Drug Delivery Devices/Systems Sales by Type
4.1.1 Global Pulmonary Drug Delivery Devices/Systems Historical Sales by Type (2017-2022)
4.1.2 Global Pulmonary Drug Delivery Devices/Systems Forecasted Sales by Type (2023-2028)
4.1.3 Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2028)
4.2 Global Pulmonary Drug Delivery Devices/Systems Revenue by Type
4.2.1 Global Pulmonary Drug Delivery Devices/Systems Historical Revenue by Type (2017-2022)
4.2.2 Global Pulmonary Drug Delivery Devices/Systems Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2028)
4.3 Global Pulmonary Drug Delivery Devices/Systems Price by Type
4.3.1 Global Pulmonary Drug Delivery Devices/Systems Price by Type (2017-2022)
4.3.2 Global Pulmonary Drug Delivery Devices/Systems Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pulmonary Drug Delivery Devices/Systems Sales by Application
5.1.1 Global Pulmonary Drug Delivery Devices/Systems Historical Sales by Application (2017-2022)
5.1.2 Global Pulmonary Drug Delivery Devices/Systems Forecasted Sales by Application (2023-2028)
5.1.3 Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2028)
5.2 Global Pulmonary Drug Delivery Devices/Systems Revenue by Application
5.2.1 Global Pulmonary Drug Delivery Devices/Systems Historical Revenue by Application (2017-2022)
5.2.2 Global Pulmonary Drug Delivery Devices/Systems Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application (2017-2028)
5.3 Global Pulmonary Drug Delivery Devices/Systems Price by Application
5.3.1 Global Pulmonary Drug Delivery Devices/Systems Price by Application (2017-2022)
5.3.2 Global Pulmonary Drug Delivery Devices/Systems Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pulmonary Drug Delivery Devices/Systems Market Size by Type
6.1.1 North America Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2028)
6.1.2 North America Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2028)
6.2 North America Pulmonary Drug Delivery Devices/Systems Market Size by Application
6.2.1 North America Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2028)
6.2.2 North America Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2028)
6.3 North America Pulmonary Drug Delivery Devices/Systems Market Size by Country
6.3.1 North America Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2028)
6.3.2 North America Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Pulmonary Drug Delivery Devices/Systems Market Size by Type
7.1.1 Europe Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2028)
7.1.2 Europe Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2028)
7.2 Europe Pulmonary Drug Delivery Devices/Systems Market Size by Application
7.2.1 Europe Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2028)
7.2.2 Europe Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2028)
7.3 Europe Pulmonary Drug Delivery Devices/Systems Market Size by Country
7.3.1 Europe Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2028)
7.3.2 Europe Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Size by Type
8.1.1 Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2028)
8.1.2 Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2028)
8.2 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Size by Application
8.2.1 Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2028)
8.2.2 Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2028)
8.3 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Size by Region
8.3.1 Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Region (2017-2028)
8.3.2 Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Pulmonary Drug Delivery Devices/Systems Market Size by Type
9.1.1 Latin America Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2028)
9.1.2 Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2028)
9.2 Latin America Pulmonary Drug Delivery Devices/Systems Market Size by Application
9.2.1 Latin America Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2028)
9.2.2 Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2028)
9.3 Latin America Pulmonary Drug Delivery Devices/Systems Market Size by Country
9.3.1 Latin America Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2028)
9.3.2 Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Market Size by Type
10.1.1 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2028)
10.2 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Market Size by Application
10.2.1 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2028)
10.3 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Market Size by Country
10.3.1 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Hovione
11.1.1 Hovione Corporation Information
11.1.2 Hovione Overview
11.1.3 Hovione Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Hovione Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Hovione Recent Developments
11.2 3M Health Care
11.2.1 3M Health Care Corporation Information
11.2.2 3M Health Care Overview
11.2.3 3M Health Care Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 3M Health Care Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 3M Health Care Recent Developments
11.3 Bespak
11.3.1 Bespak Corporation Information
11.3.2 Bespak Overview
11.3.3 Bespak Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bespak Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bespak Recent Developments
11.4 BeyonDevices
11.4.1 BeyonDevices Corporation Information
11.4.2 BeyonDevices Overview
11.4.3 BeyonDevices Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 BeyonDevices Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BeyonDevices Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
11.6 H&T Presspart
11.6.1 H&T Presspart Corporation Information
11.6.2 H&T Presspart Overview
11.6.3 H&T Presspart Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 H&T Presspart Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 H&T Presspart Recent Developments
11.7 PARI Respiratory Equipment
11.7.1 PARI Respiratory Equipment Corporation Information
11.7.2 PARI Respiratory Equipment Overview
11.7.3 PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 PARI Respiratory Equipment Recent Developments
11.8 Philips Respironics
11.8.1 Philips Respironics Corporation Information
11.8.2 Philips Respironics Overview
11.8.3 Philips Respironics Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Philips Respironics Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Philips Respironics Recent Developments
11.9 SHL
11.9.1 SHL Corporation Information
11.9.2 SHL Overview
11.9.3 SHL Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 SHL Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 SHL Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pulmonary Drug Delivery Devices/Systems Industry Chain Analysis
12.2 Pulmonary Drug Delivery Devices/Systems Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pulmonary Drug Delivery Devices/Systems Production Mode & Process
12.4 Pulmonary Drug Delivery Devices/Systems Sales and Marketing
12.4.1 Pulmonary Drug Delivery Devices/Systems Sales Channels
12.4.2 Pulmonary Drug Delivery Devices/Systems Distributors
12.5 Pulmonary Drug Delivery Devices/Systems Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pulmonary Drug Delivery Devices/Systems Industry Trends
13.2 Pulmonary Drug Delivery Devices/Systems Market Drivers
13.3 Pulmonary Drug Delivery Devices/Systems Market Challenges
13.4 Pulmonary Drug Delivery Devices/Systems Market Restraints
14 Key Findings in The Global Pulmonary Drug Delivery Devices/Systems Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Pulmonary Drug Delivery Devices/Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Metered Dose Inhalers
Table 3. Major Manufacturers of Dry Powder Inhalers
Table 4. Major Manufacturers of Nebulizers
Table 5. Major Manufacturers of Accessories
Table 6. Global Pulmonary Drug Delivery Devices/Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Pulmonary Drug Delivery Devices/Systems Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Pulmonary Drug Delivery Devices/Systems Sales by Region (2017-2022) & (K Units)
Table 9. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Region (2017-2022)
Table 10. Global Pulmonary Drug Delivery Devices/Systems Sales by Region (2023-2028) & (K Units)
Table 11. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Region (2023-2028)
Table 12. Global Pulmonary Drug Delivery Devices/Systems Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Region (2017-2022)
Table 14. Global Pulmonary Drug Delivery Devices/Systems Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Region (2023-2028)
Table 16. Global Pulmonary Drug Delivery Devices/Systems Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Pulmonary Drug Delivery Devices/Systems Sales Share by Manufacturers (2017-2022)
Table 18. Global Pulmonary Drug Delivery Devices/Systems Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Manufacturers (2017-2022)
Table 20. Pulmonary Drug Delivery Devices/Systems Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global Pulmonary Drug Delivery Devices/Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Pulmonary Drug Delivery Devices/Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Drug Delivery Devices/Systems as of 2021)
Table 23. Pulmonary Drug Delivery Devices/Systems Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Pulmonary Drug Delivery Devices/Systems Product Offered
Table 25. Date of Manufacturers Enter into Pulmonary Drug Delivery Devices/Systems Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
Table 28. Global Pulmonary Drug Delivery Devices/Systems Sales by Type (2023-2028) & (K Units)
Table 29. Global Pulmonary Drug Delivery Devices/Systems Sales Share by Type (2017-2022)
Table 30. Global Pulmonary Drug Delivery Devices/Systems Sales Share by Type (2023-2028)
Table 31. Global Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Pulmonary Drug Delivery Devices/Systems Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Type (2017-2022)
Table 34. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Type (2023-2028)
Table 35. Pulmonary Drug Delivery Devices/Systems Price by Type (2017-2022) & (USD/Unit)
Table 36. Global Pulmonary Drug Delivery Devices/Systems Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
Table 38. Global Pulmonary Drug Delivery Devices/Systems Sales by Application (2023-2028) & (K Units)
Table 39. Global Pulmonary Drug Delivery Devices/Systems Sales Share by Application (2017-2022)
Table 40. Global Pulmonary Drug Delivery Devices/Systems Sales Share by Application (2023-2028)
Table 41. Global Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Pulmonary Drug Delivery Devices/Systems Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Application (2017-2022)
Table 44. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Application (2023-2028)
Table 45. Pulmonary Drug Delivery Devices/Systems Price by Application (2017-2022) & (USD/Unit)
Table 46. Global Pulmonary Drug Delivery Devices/Systems Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
Table 48. North America Pulmonary Drug Delivery Devices/Systems Sales by Type (2023-2028) & (K Units)
Table 49. North America Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Pulmonary Drug Delivery Devices/Systems Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
Table 52. North America Pulmonary Drug Delivery Devices/Systems Sales by Application (2023-2028) & (K Units)
Table 53. North America Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Pulmonary Drug Delivery Devices/Systems Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022) & (K Units)
Table 56. North America Pulmonary Drug Delivery Devices/Systems Sales by Country (2023-2028) & (K Units)
Table 57. North America Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Pulmonary Drug Delivery Devices/Systems Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
Table 60. Europe Pulmonary Drug Delivery Devices/Systems Sales by Type (2023-2028) & (K Units)
Table 61. Europe Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Pulmonary Drug Delivery Devices/Systems Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
Table 64. Europe Pulmonary Drug Delivery Devices/Systems Sales by Application (2023-2028) & (K Units)
Table 65. Europe Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Pulmonary Drug Delivery Devices/Systems Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022) & (K Units)
Table 68. Europe Pulmonary Drug Delivery Devices/Systems Sales by Country (2023-2028) & (K Units)
Table 69. Europe Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Pulmonary Drug Delivery Devices/Systems Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Pulmonary Drug Delivery Devices/Systems Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Pulmonary Drug Delivery Devices/Systems Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Pulmonary Drug Delivery Devices/Systems Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Country (2023-2028) & (US$ Million)
Table 107. Hovione Corporation Information
Table 108. Hovione Description and Major Businesses
Table 109. Hovione Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Hovione Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Hovione Recent Developments
Table 112. 3M Health Care Corporation Information
Table 113. 3M Health Care Description and Major Businesses
Table 114. 3M Health Care Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. 3M Health Care Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. 3M Health Care Recent Developments
Table 117. Bespak Corporation Information
Table 118. Bespak Description and Major Businesses
Table 119. Bespak Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Bespak Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Bespak Recent Developments
Table 122. BeyonDevices Corporation Information
Table 123. BeyonDevices Description and Major Businesses
Table 124. BeyonDevices Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. BeyonDevices Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. BeyonDevices Recent Developments
Table 127. GlaxoSmithKline Corporation Information
Table 128. GlaxoSmithKline Description and Major Businesses
Table 129. GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. GlaxoSmithKline Recent Developments
Table 132. H&T Presspart Corporation Information
Table 133. H&T Presspart Description and Major Businesses
Table 134. H&T Presspart Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. H&T Presspart Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. H&T Presspart Recent Developments
Table 137. PARI Respiratory Equipment Corporation Information
Table 138. PARI Respiratory Equipment Description and Major Businesses
Table 139. PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. PARI Respiratory Equipment Recent Developments
Table 142. Philips Respironics Corporation Information
Table 143. Philips Respironics Description and Major Businesses
Table 144. Philips Respironics Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. Philips Respironics Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Philips Respironics Recent Developments
Table 147. SHL Corporation Information
Table 148. SHL Description and Major Businesses
Table 149. SHL Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 150. SHL Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. SHL Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Pulmonary Drug Delivery Devices/Systems Distributors List
Table 155. Pulmonary Drug Delivery Devices/Systems Customers List
Table 156. Pulmonary Drug Delivery Devices/Systems Market Trends
Table 157. Pulmonary Drug Delivery Devices/Systems Market Drivers
Table 158. Pulmonary Drug Delivery Devices/Systems Market Challenges
Table 159. Pulmonary Drug Delivery Devices/Systems Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Pulmonary Drug Delivery Devices/Systems Product Picture
Figure 3. Global Pulmonary Drug Delivery Devices/Systems Market Share by Type in 2021 & 2028
Figure 3. Metered Dose Inhalers Product Picture
Figure 4. Dry Powder Inhalers Product Picture
Figure 5. Nebulizers Product Picture
Figure 6. Accessories Product Picture
Figure 7. Global Pulmonary Drug Delivery Devices/Systems Market Share by Application in 2021 & 2028
Figure 8. Hospitals and Clinics
Figure 9. Homecare
Figure 10. Pulmonary Drug Delivery Devices/Systems Report Years Considered
Figure 11. Global Pulmonary Drug Delivery Devices/Systems Sales 2017-2028 (K Units)
Figure 12. Global Pulmonary Drug Delivery Devices/Systems Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Pulmonary Drug Delivery Devices/Systems Revenue 2017-2028 (US$ Million)
Figure 14. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Region (2017-2022)
Figure 16. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Region (2023-2028)
Figure 17. North America Pulmonary Drug Delivery Devices/Systems Sales YoY (2017-2028) & (K Units)
Figure 18. North America Pulmonary Drug Delivery Devices/Systems Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Pulmonary Drug Delivery Devices/Systems Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Pulmonary Drug Delivery Devices/Systems Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Pulmonary Drug Delivery Devices/Systems Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Pulmonary Drug Delivery Devices/Systems Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Pulmonary Drug Delivery Devices/Systems Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Pulmonary Drug Delivery Devices/Systems Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Pulmonary Drug Delivery Devices/Systems Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Pulmonary Drug Delivery Devices/Systems in the World: Market Share by Pulmonary Drug Delivery Devices/Systems Revenue in 2021
Figure 29. Global Pulmonary Drug Delivery Devices/Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2028)
Figure 31. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2028)
Figure 32. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2028)
Figure 33. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application (2017-2028)
Figure 34. North America Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2028)
Figure 35. North America Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2028)
Figure 36. North America Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2028)
Figure 37. North America Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application (2017-2028)
Figure 38. North America Pulmonary Drug Delivery Devices/Systems Sales Share by Country (2017-2028)
Figure 39. North America Pulmonary Drug Delivery Devices/Systems Revenue Share by Country (2017-2028)
Figure 40. U.S. Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2028)
Figure 43. Europe Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2028)
Figure 44. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2028)
Figure 45. Europe Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application (2017-2028)
Figure 46. Europe Pulmonary Drug Delivery Devices/Systems Sales Share by Country (2017-2028)
Figure 47. Europe Pulmonary Drug Delivery Devices/Systems Revenue Share by Country (2017-2028)
Figure 48. Germany Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 49. France Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue Share by Region (2017-2028)
Figure 59. China Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 62. India Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2028)
Figure 69. Latin America Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2028)
Figure 71. Latin America Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Pulmonary Drug Delivery Devices/Systems Sales Share by Country (2017-2028)
Figure 73. Latin America Pulmonary Drug Delivery Devices/Systems Revenue Share by Country (2017-2028)
Figure 74. Mexico Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue Share by Country (2017-2028)
Figure 83. Turkey Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
Figure 86. Pulmonary Drug Delivery Devices/Systems Value Chain
Figure 87. Pulmonary Drug Delivery Devices/Systems Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Industry Market Size
